moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
A Agilent Technologies
Post Mkt Price
Do not show
Hide blank lines
Total revenue
8.37% 6.85B 11.39% 1.85B 8.32% 1.72B 5.38% 1.61B
Operating revenue
8.37% 6.85B 11.39% 1.85B 8.32% 1.72B 5.38% 1.61B
Cost of revenue
7.35% 3.13B 10.13% 837M 6.13% 779M 5.37% 746M
Gross profit
9.25% 3.72B 12.44% 1.01B 10.21% 939M 5.39% 861M
Operating expense
2.14% 2.1B 7.13% 541M 2.33% 528M -5.29% 501M
Selling and administrative expenses
1.11% 1.64B 8.48% 422M 2.23% 412M -8.10% 386M
Research and development costs
5.90% 467M 2.59% 119M 2.65% 116M 5.50% 115M
Operating profit
20.12% 1.62B 19.24% 471M 22.32% 411M 25.00% 360M
Net non-operating interest income expense
5.06% -75M 10.00% -18M 19.05% -17M -5.26% -20M
Non-operating interest income
350.00% 9M 400.00% 5M -- 2M 0.00% 1M
Non-operating interest expense
3.70% 84M 9.52% 23M -9.52% 19M 5.00% 21M
Other net income (expense)
-142.39% -39M -97.26% 2M -75.00% 3M -275.00% -7M
Other non- operating income (expenses)
-142.39% -39M -97.26% 2M -75.00% 3M -275.00% -7M
Income before tax
10.59% 1.5B 1.56% 455M 21.41% 397M 21.98% 333M
Income tax
66.67% 250M 1,350.00% 87M 7.94% 68M 3.51% 59M
Net income
3.64% 1.25B -16.74% 368M 24.62% 329M 26.85% 274M
Net income continuous Operations
3.64% 1.25B -16.74% 368M 24.62% 329M 26.85% 274M
Minority interest income
Net income attributable to the parent company
3.64% 1.25B -16.74% 368M 24.62% 329M 26.85% 274M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.64% 1.25B -16.74% 368M 24.62% 329M 26.85% 274M
Basic earnings per share
5.28% 4.19 -15.07% 1.24 26.44% 1.1 29.58% 0.92
Diluted earnings per share
6.09% 4.18 -15.17% 1.23 27.91% 1.1 30.00% 0.91
Dividend per share
8.25% 0.84 8.25% 0.21 8.25% 0.21 8.25% 0.21
Currency Unit
Accounting Standards

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable it to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
CEO: Mr. Michael R. McMullen
Market: NYSE
Listing Date: 11/18/1999
Hot List
SymbolLatest price%Chg